TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.8333
+0.0118 (1.44%)
Sep 8, 2026, 12:28 PM EDT - Market open
TELA Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 30.42 | 50.85 | 52.67 | 46.73 | 42.02 | 43.93 |
Cash & Short-Term Investments | 30.42 | 50.85 | 52.67 | 46.73 | 42.02 | 43.93 |
Cash Growth | -13.02% | -3.46% | 12.71% | 11.21% | -4.35% | -40.95% |
Receivables | 9.64 | 10.35 | 10.1 | 9.74 | 6.62 | 4.23 |
Inventory | 11.06 | 11.02 | 12.78 | 13.16 | 11.79 | 7.66 |
Prepaid Expenses | 3.37 | 3.37 | 2.52 | 2.1 | 2.02 | 3.23 |
Total Current Assets | 54.49 | 75.58 | 78.07 | 71.73 | 62.45 | 59.06 |
Property, Plant & Equipment | 3.43 | 3.73 | 4.08 | 3.94 | 2.91 | 1.19 |
Other Intangible Assets | 1.17 | 1.36 | 1.74 | 2.12 | 2.5 | 2.3 |
Long-Term Deferred Tax Assets | - | - | 0.14 | - | - | - |
Other Long-Term Assets | 0.65 | 0.75 | 2.54 | 0.27 | - | - |
Total Assets | 59.74 | 81.42 | 86.57 | 78.05 | 67.86 | 62.54 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.88 | 2.31 | 2.15 | 1.67 | 1.53 | 2.41 |
Accrued Expenses | 7.26 | 7.12 | 7.36 | 9.36 | 6.56 | 5.01 |
Current Portion of Leases | 0.53 | 0.52 | 0.55 | 0.57 | 0.34 | - |
Current Income Taxes Payable | 0.86 | 0.73 | 0.48 | - | - | - |
Other Current Liabilities | 6.68 | 7.29 | 5.07 | 5.38 | 3.97 | 3.15 |
Total Current Liabilities | 18.22 | 17.98 | 15.6 | 16.97 | 12.4 | 10.58 |
Long-Term Debt | 56.08 | 55.65 | 41.12 | 40.52 | 39.92 | 31.49 |
Long-Term Leases | 1.31 | 1.48 | - | 1.69 | - | - |
Other Long-Term Liabilities | - | - | 1.39 | - | 1.23 | 0.38 |
Total Liabilities | 75.6 | 75.11 | 58.11 | 59.17 | 53.55 | 42.45 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.05 | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 |
Additional Paid-In Capital | 405.1 | 403.74 | 387.06 | 339.66 | 288.36 | 250.06 |
Retained Earnings | -421.1 | -397.56 | -358.73 | -320.89 | -274.23 | -229.93 |
Comprehensive Income & Other | 0.08 | 0.09 | 0.09 | 0.09 | 0.15 | -0.05 |
Total Common Equity | -15.87 | 6.31 | 28.46 | 18.88 | 14.31 | 20.1 |
Shareholders' Equity | -15.87 | 6.31 | 28.46 | 18.88 | 14.31 | 20.1 |
Total Liabilities & Equity | 59.74 | 81.42 | 86.57 | 78.05 | 67.86 | 62.54 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 57.92 | 57.65 | 41.67 | 42.77 | 40.26 | 31.49 |
Net Cash (Debt) | -27.49 | -6.81 | 11 | 3.96 | 1.76 | 12.44 |
Net Cash Growth | - | - | 177.52% | 124.84% | -85.83% | -71.45% |
Net Cash Per Share | -0.52 | -0.15 | 0.39 | 0.17 | 0.11 | 0.86 |
Filing Date Shares Outstanding | 44.89 | 44.74 | 39.55 | 24.65 | 19.22 | 14.55 |
Total Common Shares Outstanding | 44.83 | 44.54 | 39.4 | 24.49 | 19.17 | 14.53 |
Working Capital | 36.27 | 57.61 | 62.47 | 54.76 | 50.04 | 48.48 |
Book Value Per Share | -0.35 | 0.14 | 0.72 | 0.77 | 0.75 | 1.38 |
Tangible Book Value | -17.04 | 4.95 | 26.72 | 16.76 | 11.81 | 17.8 |
Tangible Book Value Per Share | -0.38 | 0.11 | 0.68 | 0.68 | 0.62 | 1.22 |
Machinery | - | 3.18 | 4.07 | 3.81 | 3.51 | 3.06 |
Leasehold Improvements | - | 2.54 | 2.93 | 2.51 | 2.31 | 1.88 |